Skip to content Skip to footer
Xembify: Benefits, Reviews, Info, Side Effects!
Rx Details
Xembify
Immune globulin subcutaneous (human), IgSC, SCIG, subcutaneous immunoglobulin
Immune Globulin Subcutaneous (Human)
Prescription
Immunoglobulin
Vitamins
Biologic
increases immunoglobulin levels, supports immune system function, reduces frequency of infections, provides passive immunity, used in primary immunodeficiency treatment
Back Pain, Cough, Diarrhea, Fatigue, Fever, Headache, Injection Site Reactions, Nausea, Sinusitis, Upper Respiratory Tract Infection
Xembify is a brand of immune globulin subcutaneous (human), used for treating primary immunodeficiency (PI) in patients. The dosage of Xembify is individualized based on the patient’s clinical response and serum IgG trough levels. Typically, the dosage is calculated based on the patient’s body weight and the desired IgG trough level. For adults and children over 2 years of age, the initial dose is often determined by the previous intravenous immunoglobulin (IVIG) dose, adjusted to account for the difference in bioavailability between IVIG and subcutaneous administration. The typical maintenance dose is around 100 to 200 mg/kg body weight per week, but this can vary. It’s important for patients to follow their healthcare provider’s specific dosage instructions. Always consult with a healthcare professional for precise dosing tailored to individual needs.
Primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy
Xembify has a favorable safety profile.
No Interactions Reported
$1,000 – $2,000
$6,000

A Synopsis of

Xembify

Xembify is a medication that is used to treat primary immunodeficiency (PI) in patients who are two years of age and older. This condition occurs when the immune system is not able to function properly, leaving individuals more susceptible to infections. Xembify works by providing the body with immunoglobulin G (IgG) antibodies, which help to boost the immune system and protect against infections.

One of the key benefits of Xembify is its convenience. It is administered subcutaneously, meaning it is injected under the skin, which can be done at home by the patient or caregiver after proper training from a healthcare provider. This allows for more flexibility and independence in managing the condition.

It is important to follow the dosing schedule prescribed by your healthcare provider to ensure the medication is effective. Xembify is typically given once a week, but the dosage may vary depending on the individual’s specific needs. It is important to monitor for any side effects and report them to your healthcare provider.

As with any medication, there are potential side effects associated with Xembify. These may include headache, fatigue, fever, and injection site reactions. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.

Overall, Xembify is a valuable treatment option for individuals with primary immunodeficiency. It can help to improve quality of life by reducing the frequency and severity of infections. If you have been diagnosed with PI, talk to your healthcare provider to see if Xembify may be a suitable treatment option for you.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN